Workflow
SINYUAN ZM(301398)
icon
Search documents
星源卓镁(301398) - 容诚会计师事务所(特殊普通合伙)关于宁波星源卓镁技术股份有限公司申请向不特定对象发行可转换公司债券审核问询函的回复
2025-08-14 03:52
容诚会计师事务所(特殊普通合伙) 中国·北京 关于宁波星源卓镁技术股份有限公司申请向不 特定对象发行可转换公司债券的审核问询函 相关问题的核查情况说明 宁波星源卓镁技术股份有限公司 容诚专字[2025]230Z1503 号 深圳证券交易所: 贵所于 2025 年 4 月 10 日出具的审核函〔2025〕020012 号《关于宁波星源 卓镁技术股份有限公司申请向不特定对象发行可转换公司债券的审核问询函》 (以下简称"问询函")已收悉。我们本着勤勉尽责、诚实守信的原则,就问询 函所提问题逐条进行了认真讨论、核查和落实,现回复如下,请予以审核。 关于回复内容释义、格式及补充更新披露等事项的说明: 1、除非文义另有所指,本问询函回复中的简称与《宁波星源卓镁技术股份 有限公司向不特定对象发行可转换公司债券募集说明书(申报稿)》(以下简称 "募集说明书")中的释义具有相同涵义。涉及问询函所列问题、回复的列示方 式如下表所示: | 问询函所列问题 | 黑体(不加粗) | | --- | --- | | 对问询函所列问题的回复 | 宋体(不加粗) | | 对问询函所列问题回复的补充、修改 | 楷体(加粗) | 2、本回复中若 ...
星源卓镁(301398) - 关于宁波星源卓镁技术股份有限公司申请向不特定对象发行可转换公司债券的审核问询函回复
2025-08-14 03:52
关于宁波星源卓镁技术股份有限公司 申请向不特定对象发行可转换公司债券 的审核问询函回复 保荐机构(主承销商) (广东省深圳市福田区福田街道福华一路 119 号安信金融大厦) 二〇二五年七月 深圳证券交易所: 贵所于 2025 年 4 月 10 日出具的审核函〔2025〕020012 号《关于宁波星源 卓镁技术股份有限公司申请向不特定对象发行可转换公司债券的审核问询函》 (以下简称"问询函")已收悉。宁波星源卓镁技术股份有限公司(以下简称"星 源卓镁"、"发行人"、"公司")会同国投证券股份有限公司(以下简称"保 荐机构"、"保荐人")、北京德恒律师事务所(以下简称"发行人律师")、 容诚会计师事务所(特殊普通合伙)(以下简称"会计师")等相关方,本着勤 勉尽责、诚实守信的原则,就问询函所提问题逐条进行了认真讨论、核查和落实, 现回复如下,请予审核。 关于回复内容释义、格式及补充更新披露等事项的说明: 1、除非文义另有所指,本问询函回复中的简称与《宁波星源卓镁技术股份 有限公司向不特定对象发行可转换公司债券募集说明书(修订稿)》(以下简称 "募集说明书")中的释义具有相同涵义。涉及问询函所列问题、回复的列示方 ...
星源卓镁(301398) - 北京德恒律师事务所关于宁波星源卓镁技术股份有限公司申请向不特定对象发行可转换公司债券的补充法律意见书(一)
2025-08-14 03:52
北京德恒律师事务所 关于 宁波星源卓镁技术股份有限公司 向不特定对象发行可转换公司债券的 补充法律意见(一) 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 | 第一部分问询函回复 | 4 | | --- | --- | | 问题 3 | 4 | | 第二部分补充事项期间重大事项更新 | 27 | | 一、本次发行的批准和授权 | 27 | | 二、发行人本次发行的主体资格 | 27 | | 三、本次发行的实质条件 | 27 | | 四、发行人的独立性 | 32 | | 五、发行人的发起人和股东 | 32 | | 六、发行人的股本及其演变 | 34 | | 七、发行人的业务 | 34 | | 八、关联交易及同业竞争 | 35 | | 九、发行人的主要财产 | 38 | | 十、发行人的重大债权债务 | 38 | | 十一、发行人重大资产变化及收购兼并 | 40 | | 十二、发行人章程的制定与修改 | 40 | | 十三、发行人股东大会、董事会、监事会议事规则及规范运作 | 40 | | 十四、发行人董事、监事和高级管 ...
星源卓镁(301398) - 关于向不特定对象发行可转换公司债券的审核问询函回复等申请文件更新的提示性公告
2025-08-14 03:52
证券代码:301398 证券简称:星源卓镁 公告编号:2025-032 宁波星源卓镁技术股份有限公司 申请文件更新的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 宁波星源卓镁技术股份有限公司(以下简称"公司")于 2025 年 4 月 10 日 收到深圳证券交易所(以下简称"深交所")出具的《关于宁波星源卓镁技术股 份有限公司申请向不特定对象发行可转换公司债券的审核问询函》(审核函〔2025〕 020012 号)(以下简称"审核问询函")。深交所上市审核中心对公司提交的向 不特定对象发行可转换公司债券的申请文件进行了审核,并形成了审核问询问题。 公司于2025年4月29日在巨潮资讯网(http://www.cninfo.com.cn)上披露了《关 于宁波星源卓镁技术股份有限公司申请向不特定对象发行可转换公司债券的审核 问询函回复》等相关文件。 根据本次发行项目进展,结合公司已披露的《2025年一季度报告》,公司按 照相关要求会同中介机构对审核问询函回复进行了修订和补充,并对募集说明书 等申请文件涉及的财务数据进行了同步更新,具体内容详见公司同日在 ...
星源卓镁(301398)8月13日主力资金净流出1057.41万元
Sou Hu Cai Jing· 2025-08-13 11:06
金融界消息 截至2025年8月13日收盘,星源卓镁(301398)报收于46.84元,上涨6.67%,换手率 36.31%,成交量12.15万手,成交金额5.59亿元。 资金流向方面,今日主力资金净流出1057.41万元,占比成交额1.89%。其中,超大单净流出645.86万 元、占成交额1.15%,大单净流出411.55万元、占成交额0.74%,中单净流出流出3664.01万元、占成交 额6.55%,小单净流入4721.42万元、占成交额8.44%。 通过天眼查大数据分析,宁波星源卓镁技术股份有限公司共对外投资了3家企业,参与招投标项目16 次,知识产权方面有商标信息15条,专利信息87条,此外企业还拥有行政许可17个。 来源:金融界 星源卓镁最新一期业绩显示,截至2025一季报,公司营业总收入8833.78万元、同比增长7.28%,归属净 利润1693.95万元,同比减少4.08%,扣非净利润1593.06万元,同比减少6.46%,流动比率7.414、速动比 率6.549、资产负债率10.00%。 天眼查商业履历信息显示,宁波星源卓镁技术股份有限公司,成立于2003年,位于宁波市,是一家以从 事专用设备制 ...
汽车零部件板块8月12日涨0.07%,毓恬冠佳领涨,主力资金净流出24.08亿元
Core Insights - The automotive parts sector experienced a slight increase of 0.07% on August 12, with Yutian Guanjia leading the gains [1] - The Shanghai Composite Index closed at 3665.92, up 0.5%, while the Shenzhen Component Index closed at 11351.63, up 0.53% [1] Automotive Parts Sector Performance - Yutian Guanjia (301173) saw a significant rise of 12.11%, closing at 53.25 with a trading volume of 79,900 shares and a transaction value of 426 million [1] - Other notable gainers included: - Xinpeng Co., Ltd. (002328) up 10.02% to 6.81 with a volume of 607,000 shares [1] - Weidi Co., Ltd. (603023) up 10.00% to 4.62 with a volume of 482,300 shares [1] - Liangyuan Zhuomei (301398) up 9.67% to 43.91 with a volume of 103,100 shares [1] - Huamao Technology (603306) up 8.39% to 46.90 with a volume of 195,200 shares [1] Capital Flow Analysis - The automotive parts sector saw a net outflow of 2.408 billion from institutional investors, while retail investors contributed a net inflow of 2.071 billion [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - Top stocks by net inflow from institutional investors included: - Top Group (601689) with a net inflow of 158 million [3] - Hai Lian Jin Hui (002537) with a net inflow of 109 million [3] - Xinpeng Co., Ltd. (002328) with a net inflow of 97.72 million [3] - Conversely, stocks like Yutian Guanjia (301173) experienced a net outflow of 30.10 million from retail investors [3]
星源卓镁:公司始终密切关注行业技术发展趋势及市场需求动态
Zheng Quan Ri Bao· 2025-08-08 11:45
Group 1 - The company is focusing on lightweight magnesium alloy components for humanoid robots and is actively exploring technology development and market expansion [2] - The company emphasizes the importance of monitoring industry technology trends and market demand dynamics [2] - Relevant operational information should be referenced from the company's publicly disclosed periodic reports [2]
每天三分钟公告很轻松 | 百济神州:上半年实现净利润4.5亿元同比扭亏为盈
Group 1 - BeiGene reported a net profit of 450 million yuan for the first half of 2025, reversing a loss of 287.7 million yuan in the same period last year, with a total revenue of 17.518 billion yuan, up 46.0% year-on-year [1] - The company attributed the profit increase to significant growth in product revenue and improved operational efficiency through cost management [1] Group 2 - Tianyang Technology is planning to acquire a portion of the equity in Tonglian Financial Services Co., Ltd. and related companies, aiming to enhance its competitive advantage in credit card and consumer finance system services [2] - The acquisition is expected to create synergies in areas such as industry positioning, product development, and technical services [2] Group 3 - ST Yazhen's stock experienced abnormal trading fluctuations, with a cumulative price increase of 12% over three consecutive trading days, leading to a suspension of trading for investigation starting August 7, 2025 [3] - The company noted that the short-term price increase significantly deviated from the Shanghai Composite Index and the furniture manufacturing industry [3] Group 4 - Shunbo Alloy reported a revenue of approximately 7.126 billion yuan for the first half of 2025, an increase of 11.75% year-on-year, with a net profit of about 176.6 million yuan, up 110.56% [4] - Tapa Group achieved a revenue of approximately 2.056 billion yuan, a 4.05% increase year-on-year, with a net profit of about 435.4 million yuan, up 92.47% [4] - Liyuan Information reported a revenue of approximately 4.034 billion yuan, a 17.46% increase year-on-year, with a net profit of about 96.1 million yuan, up 65.79% [5] Group 5 - Zhongchumei reported a revenue of approximately 461.1 million yuan for the first half of 2025, a 16.46% increase year-on-year, with a net profit of about 126.8 million yuan, up 31.52% [5] - Pudong Development Bank reported a revenue of approximately 90.559 billion yuan, a 2.62% increase year-on-year, with a net profit of about 29.737 billion yuan, up 10.19% [5]
百济神州:上半年净利润4.5亿元 同比扭亏为盈丨公告精选
Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved an operating income of 4.258 billion yuan and a net profit of 1.123 billion yuan in the first half of 2025, with total comprehensive income of 1.106 billion yuan [3] - Shanghai Pudong Development Bank's net profit for the first half of 2025 was 29.737 billion yuan, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [6] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [7] - Shengmei Shanghai reported a net profit of 696 million yuan for the first half of 2025, representing a year-on-year increase of 56.99% [14] Group 2: Regulatory and Corporate Actions - Sino Medical's subsidiary received breakthrough medical device designation from the FDA for its intracranial atherosclerosis treatment product, marking it as the first of its kind globally [2] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Tianyang Technology is planning to purchase equity in Tonglian Financial Services, with key transaction details still under negotiation [10] - Dongfang Guoxin's major shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [5] - Filinger's president reduced his holdings by 8,600 shares during a period of stock price volatility, while other executives did not sell shares [4]
百济神州:上半年净利润4.5亿元,同比扭亏为盈丨公告精选
Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved a net profit of 1.123 billion yuan in the first half of 2025, with total operating income of 4.258 billion yuan and total comprehensive income of 1.106 billion yuan [1] - Shanghai Pudong Development Bank reported a net profit of 29.737 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [4] - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [5] - Shunbo Alloy reported a net profit growth of 110.56% year-on-year for the first half of 2025 [12] Group 2: Regulatory and Corporate Actions - Sino Medical announced that its subsidiary received breakthrough medical device designation from the FDA for a new intracranial atherosclerosis treatment product, marking a significant milestone as the first of its kind globally [1] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6][7] - Tianyang Technology is planning to purchase equity in Tonglian Jinfu and related companies, with key transaction details still under negotiation [8] - Filinger reported stock price fluctuations, with the president reducing his holdings by 8,600 shares during a period of abnormal trading activity [2] - Dongfang Guoxin's controlling shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [3]